Yeji
FDA approvalconf 0.75

FDA approval

$ALKS · Alkermes plc.
Event date
Date TBD
Sponsor runway
6 mo
$351.6M liquid

Evidence

“contingent upon final FDA approval of LUMRYZ ® for the treatment of idiopathic hypersomnia in adults by the end of 2028”
Source: Press release · 2025-10-22View press release ↗

Comparable historical fda approvals· last 5 years · same event type

100% hit rate (10/10)
TickerDrugDateOutcome
$INCYzynyz2026-05-18success
$INCYjakafi xr2026-05-01success
$AXSMauvelity2026-04-30success
$INCYzynyz2026-03-30success
$BIIBspinraza2026-03-27success
$CORTlifyorli2026-03-25success
$RYTMimcivree2026-03-19success
$ASNDyuviwel2026-02-27success
$BMRNpalynziq2026-02-27success
$ETONdesmoda2026-02-25success

Recent insider activity· ±90 days

10 insiders · 0 buys · 4 sells
Exercise
2026-05-21
Lurker Nancy
Director
6,142 @ ——
Tax
2026-05-21
LAURENCIN CATO T
Director
1,475 @ $36.95$55K
Exercise
2026-05-21
GAYNOR RICHARD
Director
6,142 @ ——
Tax
2026-05-21
GAYNOR RICHARD
Director
1,475 @ $36.95$55K
Exercise
2026-05-21
Wright Christopher I
Director
6,142 @ ——
Exercise
2026-05-21
LAURENCIN CATO T
Director
6,142 @ ——
Exercise
2026-05-21
MCKEON BRIAN P
Director
6,142 @ ——
Tax
2026-05-21
MCKEON BRIAN P
Director
1,475 @ $36.95$55K
Tax
2026-05-21
snyderman nancy lynn MD
Director
1,475 @ $36.95$55K
Exercise
2026-05-21
snyderman nancy lynn MD
Director
6,142 @ ——
Exercise
2026-05-21
Cooke Shane
Director
6,142 @ ——
Tax
2026-05-21
Cooke Shane
Director
3,207 @ $36.95$118K
Tax
2026-05-21
Wright Christopher I
Director
1,475 @ $36.95$55K
Tax
2026-05-21
Lurker Nancy
Director
1,475 @ $36.95$55K
Exercise
2026-05-21
Wilson Frank Anders
Director
6,142 @ ——
Tax
2026-05-21
Wilson Frank Anders
Director
1,475 @ $36.95$55K
Grant
2026-05-20
GAYNOR RICHARD
Director
11,538 @ ——
Grant
2026-05-20
Wright Christopher I
Director
11,538 @ ——
Grant
2026-05-20
Wright Christopher I
Director
5,409 @ ——
Grant
2026-05-20
Cooke Shane
Director
11,538 @ ——
Grant
2026-05-20
Cooke Shane
Director
5,409 @ ——
Grant
2026-05-20
Wilson Frank Anders
Director
11,538 @ ——
Grant
2026-05-20
Wilson Frank Anders
Director
5,409 @ ——
Grant
2026-05-20
GAYNOR RICHARD
Director
5,409 @ ——
Grant
2026-05-20
MCKEON BRIAN P
Director
11,538 @ ——
Grant
2026-05-20
MCKEON BRIAN P
Director
5,409 @ ——
Grant
2026-05-20
snyderman nancy lynn MD
Director
11,538 @ ——
Grant
2026-05-20
snyderman nancy lynn MD
Director
5,409 @ ——
Grant
2026-05-20
LAURENCIN CATO T
Director
11,538 @ ——
Grant
2026-05-20
LAURENCIN CATO T
Director
5,409 @ ——
Grant
2026-05-20
Lurker Nancy
Director
11,538 @ ——
Grant
2026-05-20
Lurker Nancy
Director
5,409 @ ——
Sell10b5-1
2026-05-04
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
2,034 @ $33.20$68K
Sell10b5-1
2026-05-01
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
9,000 @ $33.40$301K
Exercise10b5-1
2026-05-01
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
5,000 @ $19.34$97K
Exercise
2026-04-11
Lurker Nancy
Director
3,751 @ ——
Tax
2026-04-11
Lurker Nancy
Director
901 @ $33.36$30K
Sell10b5-1
2026-04-06
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
2,034 @ $34.57$70K
Exercise10b5-1
2026-04-01
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
5,000 @ $19.34$97K
Sell10b5-1
2026-04-01
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
9,000 @ $35.51$320K
← All catalysts for $ALKS